Page last updated: 2024-08-25

artemisinin and Leukemia

artemisinin has been researched along with Leukemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Ackermann, L; Belyakova, YY; Çapcı, A; Dheeraj, A; Herrmann, L; Hodek, J; Malhotra, SV; Radulov, PS; Struwe, J; Tailor, D; Terent'ev, AO; Tsogoeva, SB; Weber, J; Yaremenko, IA1
Hristova-Avakumova, NG; Momekov, GT; Zhelyazkova, MY1
Chen, H; Cui, J; Dai, T; Lin, L; Liu, Y; Lu, W; Sun, D; Yang, L; Yang, X1
Arav-Boger, R; Chen, X; Civin, CI; Fox, JM; He, R; Mott, BT; Posner, GH1
Lai, HC; Park, J; Sasaki, T; Singh, M; Singh, NP1
Bahsi, H; Efferth, T; Friedrich, O; Fröhlich, T; Hampel, F; Kappes, B; Leidenberger, M; Marschall, M; Reiter, C; Tsogoeva, SB; Zeino, M1
Kim, BJ; Lai, H; Oh, S; Sasaki, T; Singh, NP1

Other Studies

7 other study(ies) available for artemisinin and Leukemia

ArticleYear
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and Cancer.
    ChemMedChem, 2022, 05-04, Volume: 17, Issue:9

    Topics: Animals; Antiviral Agents; Artemisinins; Chlorocebus aethiops; COVID-19 Drug Treatment; Humans; Leukemia; Neoplasms; Peroxides; Quinolines; SARS-CoV-2; Vero Cells

2022
Antitumor activity of the combination of artemisinin and epirubicin in human leukemia cells.
    Folia medica, 2021, Aug-31, Volume: 63, Issue:4

    Topics: Anthracyclines; Artemisinins; Deoxyribose; Doxorubicin; Drug Synergism; Epirubicin; Humans; Iron; Lecithins; Leukemia

2021
Novel nitrogen mustard-artemisinin hybrids with potent anti-leukemia action through DNA damage and activation of GPx.
    European journal of medicinal chemistry, 2022, Dec-15, Volume: 244

    Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; DNA Damage; Glutathione Peroxidase; Humans; Leukemia; Mechlorethamine; Neoplasms

2022
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study.
    Bioorganic & medicinal chemistry, 2013, Jul-01, Volume: 21, Issue:13

    Topics: Antineoplastic Agents; Antiviral Agents; Artemisinins; Cytomegalovirus; Cytomegalovirus Infections; Dimerization; Esters; Humans; Jurkat Cells; Leukemia; Phosphates

2013
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
    Anticancer research, 2014, Volume: 34, Issue:6

    Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia; Transferrin; Tumor Cells, Cultured

2014
New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids.
    European journal of medicinal chemistry, 2015, Jun-05, Volume: 97

    Topics: Artemisinins; Cell Line, Tumor; Drug Resistance, Multiple; Ferrous Compounds; Heterocyclic Compounds; Heterocyclic Compounds, 4 or More Rings; Humans; Inhibitory Concentration 50; Leukemia; Metallocenes; Plasmodium falciparum

2015
Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide.
    Cancer letters, 2009, Feb-08, Volume: 274, Issue:1

    Topics: Antineoplastic Agents; Artemisia; Artemisinins; Cells, Cultured; Humans; Leukemia; Leukocytes; Peptide Fragments; Receptors, Transferrin; Recombinant Fusion Proteins; Transferrin

2009